Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

14.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

10.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.0K
Inflammation01:38

Inflammation

62.8K
Overview
62.8K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

17.4K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Introduction to Hemostasis01:05

Introduction to Hemostasis

15.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhage.

Platelets·2016
Same author

LDL receptor-related protein 1 contributes to the clearance of the activated factor VII-antithrombin complex.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.

Journal of thrombosis and haemostasis : JTH·2015

Related Experiment Video

Updated: Feb 27, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.9K

von Willebrand factor and inflammation.

C Kawecki1,2,3, P J Lenting1, C V Denis1

  • 1Institut National de la Santé et de la Recherche Médicale, UMR_S 1176, Univ. Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Journal of Thrombosis and Haemostasis : JTH
|July 4, 2017
PubMed
Summary

Von Willebrand factor (VWF) is a key protein in blood clotting and inflammation. This review explores VWF's multifaceted role in immune responses and its interactions with leukocytes, highlighting its significance in immuno-thrombosis.

Keywords:
Weibel-Palade bodiesendotheliuminflammationleukocytesvon Willebrand factor

More Related Videos

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

11.3K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

12.3K

Related Experiment Videos

Last Updated: Feb 27, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.9K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

11.3K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

12.3K

Area of Science:

  • Hematology
  • Immunology
  • Vascular Biology

Background:

  • Von Willebrand factor (VWF) is a critical glycoprotein in hemostasis, bridging platelets to injured subendothelial structures and chaperoning coagulation factor VIII.
  • VWF is implicated in arterial and venous thrombosis, acting as both a risk factor and a direct promoter of thrombotic processes.
  • The interplay between hemostasis and inflammation, termed immuno-thrombosis, is increasingly recognized, with growing evidence linking hemostatic components to inflammatory responses.

Purpose of the Study:

  • To review the evolving understanding of the connection between Von Willebrand factor (VWF) and inflammation.
  • To emphasize the intricate VWF-leukocyte interactions in the context of inflammation and thrombosis.
  • To explore VWF's role beyond hemostasis, particularly in inflammatory pathways.

Main Methods:

  • Literature review focusing on the relationship between VWF and inflammatory processes.
  • Analysis of studies investigating VWF's involvement in endothelial function and immune cell recruitment.
  • Synthesis of evidence detailing VWF's direct and indirect mechanisms in inflammation.

Main Results:

  • VWF initially recognized as an inflammation marker due to endothelial release.
  • VWF's role expanded with its involvement in Weibel-Palade body biogenesis, housing inflammatory mediators like P-selectin.
  • VWF directly recruits leukocytes through binding or by attracting platelets, which subsequently recruit leukocytes.

Conclusions:

  • Von Willebrand factor plays a complex and direct role in inflammatory responses, extending beyond its hemostatic functions.
  • VWF-leukocyte interactions are a key mechanism linking thrombosis and inflammation.
  • Understanding VWF's role in inflammation is crucial for developing novel therapeutic strategies for thrombotic and inflammatory diseases.